MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6

FEBS Letters

Volumn 588, Issue 20, 2014, Pages 3744-3750

  Han, Hye Sook ^a   Son, Seung Myoung ^a   Yun, Jieun ^b   Jo, Yeong Nang ^b   Lee, Ok Jun ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

adhesion molecule 6; Carcinoembryonic antigen related cell; Lung adenocarcinoma; MicroRNA 29a

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; MICRORNA 29A; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; MICRORNA; MIRN29 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CARCINOMA CELL; CEACAM6 GENE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; RNA ANALYSIS; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; CELL MOTION; CELL PROLIFERATION; EXPERIMENTAL NEOPLASM; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION;

CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; LUNG ADENOCARCINOMA; MICRORNA 29A;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GPI-LINKED PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; PROGNOSIS;

EID: 84907284875     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.08.023     Document Type: Article

References (37)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, R. Rami-Porta, P.E. Postmus, V. Rusch, and L. Sobin International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J. Thorac. Oncol. 2 2007 706 714
3. D.S. Ettinger, W. Akerley, H. Borghaei, A.C. Chang, R.T. Cheney, L.R. Chirieac, T.A. D'Amico, T.L. Demmy, R. Govindan, F.W. Grannis Jr., S.C. Grant, L. Horn, T.M. Jahan, R. Komaki, F.M. Kong, M.G. Kris, L.M. Krug, R.P. Lackner, I.T. Lennes, B.W. Loo Jr., R. Martins, G.A. Otterson, J.D. Patel, M.C. Pinder-Schenck, K.M. Pisters, K. Reckamp, G.J. Riely, E. Rohren, T.A. Shapiro, S.J. Swanson, K. Tauer, D.E. Wood, S.C. Yang, K. Gregory, and M. Hughes National comprehensive cancer network: non-small cell lung cancer, version 2.2013 J. Natl. Compr. Canc. Netw. 11 2013 645 653
4. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
5. K. Kuespert, S. Pils, and C.R. Hauck CEACAMs: their role in physiology and pathophysiology Curr. Opin. Cell Biol. 18 2006 565 571
6. N. Beauchemin, and A. Arabzadeh Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis Cancer Metastasis Rev. 32 2013 643 671
7. S.A. Hefta, R.J. Paxton, and J.E. Shively Sequence and glycosylation site identity of two distinct glycoforms of nonspecific cross-reacting antigen as demonstrated by sequence analysis and fast atom bombardment mass spectrometry Biol. Chem. 265 1990 8618 8626
8. S. Oikawa, M. Sugiyama, M. Kuroki, M. Kuroki, and H. Nakazato Extracellular N-domain alone can mediate specific heterophilic adhesion between members of the carcinoembryonic antigen family, CEACAM6 and CEACAM8 Biochem. Biophys. Res. Commun. 278 2000 564 568
9. R.D. Blumenthal, H.J. Hansen, and D.M. Goldenberg Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen) Cancer Res. 65 2005 8809 8817
10. R.D. Blumenthal, E. Leon, H.J. Hansen, and D.M. Goldenberg Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers BMC Cancer 7 2007 2
11. M.S. Duxbury, H. Ito, E. Benoit, S.W. Ashley, and E.E. Whang CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness Br. J. Cancer 91 2004 1384 1390
12. M.S. Duxbury, E. Matros, T. Clancy, G. Bailey, M. Doff, M.J. Zinner, S.W. Ashley, A. Maitra, M. Redston, and E.E. Whang CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions Ann. Surg. 241 2005 491 496
13. S. Schölzel, W. Zimmermann, G. Schwarzkopf, F. Grunert, B. Rogaczewski, and J. Thompson Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas Am. J. Pathol. 156 2000 595 605
14. P. Jantscheff, L. Terracciano, A. Lowy, K. Glatz-Krieger, F. Grunert, B. Micheel, J. Brümmer, U. Laffer, U. Metzger, R. Herrmann, and C. Rochlitz Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance J. Clin. Oncol. 21 2003 3638 3646
15. J.S. Lewis-Wambi, H.E. Cunliffe, H.R. Kim, A.L. Willis, and V.C. Jordan Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells Eur. J. Cancer 44 2008 1770 1779
16. B.B. Singer, I. Scheffrahn, R. Kammerer, N. Suttorp, S. Ergun, and H. Slevogt Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells PLoS ONE 5 2010 e8747
17. M. Kobayashi, Y. Miki, M. Ebina, K. Abe, K. Mori, S. Narumi, T. Suzuki, I. Sato, M. Maemondo, C. Endo, A. Inoue, H. Kumamoto, T. Kondo, H. Yamada-Okabe, T. Nukiwa, and H. Sasano Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma Br. J. Cancer 107 2012 1745 1753
18. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
19. W.C. Cho MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy Int. J. Biochem. Cell Biol. 42 2010 1273 1281
20. C. Ordonez, A.B. Zhai, P. Camacho-Leal, L. Demarte, M.M. Fan, and C.P. Stanners GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction J. Cell. Physiol. 210 2007 757 765
21. M.S. Duxbury, H. Ito, M.J. Zinner, S.W. Ashley, and E.E. Whang CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells Oncogene 23 2004 465 473
22. V. Kanderová, O. Hrusák, and T. Kalina Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells Exp. Hematol. 38 2010 653 660
23. M.S. Duxbury, H. Ito, E. Benoit, M.J. Zinner, S.W. Ashley, and E.E. Whang A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells Cancer Res. 64 2004 3987 3993
24. J. Chen, Q. Li, Y. An, N. Lv, X. Xue, J. Wei, K. Jiang, J. Wu, W. Gao, Z. Qian, C. Dai, Z. Xu, and Y. Miao CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer Int. J. Oncol. 43 2013 877 885
25. K.S. Kim, J.T. Kim, S.J. Lee, M.A. Kang, I.S. Choe, Y.H. Kang, S.Y. Kim, Y.I. Yeom, Y.H. Lee, J.H. Kim, K.H. Kim, C.N. Kim, J.W. Kim, M.S. Nam, and H.G. Lee Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer Clin. Chim. Acta 415 2013 12 19
26. L. Maraqa, M. Cummings, M.B. Peter, A.M. Shaaban, K. Horgan, A.M. Hanby, and V. Speirs Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen Clin. Cancer Res. 14 2008 405 411
27. Y. Wang, X. Zhang, H. Li, J. Yu, and X. Ren The role of miRNA-29 family in cancer Eur. J. Cell Biol. 92 2013 123 128
28. H. Jiang, G. Zhang, J.H. Wu, and C.P. Jiang Diverse roles of miR-29 in cancer (review) Oncol. Rep. 31 2014 1509 1516
29. G.A. Calin, M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, M. Fabbri, R. Iuliano, T. Palumbo, F. Pichiorri, C. Roldo, R. Garzon, C. Sevignani, L. Rassenti, H. Alder, S. Volinia, C.G. Liu, T.J. Kipps, M. Negrini, and C.M. Croce A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N. Engl. J. Med. 353 2005 1793 1801
30. S. Sengupta, J.A. Den Boon, I.H. Chen, M.A. Newton, S.A. Stanhope, Y.J. Cheng, C.J. Chen, A. Hildesheim, B. Sugden, and P. Ahlquist MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins Proc. Natl. Acad. Sci. U.S.A. 105 2008 5874 5878
31. Y. Xiong, J.H. Fang, J.P. Yun, J. Yang, Y. Zhang, W.H. Jia, and S.M. Zhuang Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma Hepatology 51 2010 836 845
32. J.J. Zhao, J. Lin, T. Lwin, H. Yang, J. Guo, W. Kong, S. Dessureault, L.C. Moscinski, D. Rezania, W.S. Dalton, E. Sotomayor, J. Tao, and J.Q. Cheng MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma Blood 115 2010 2630 2639
33. C.A. Gebeshuber, K. Zatloukal, and J. Martinez MiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis EMBO Rep. 10 2009 400 405
34. M.K. Muniyappa, P. Dowling, M. Henry, P. Meleady, P. Doolan, P. Gammell, M. Clynes, and N. Barron MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines Eur. J. Cancer 45 2009 3104 3118
35. M. Fabbri, R. Garzon, A. Cimmino, Z. Liu, N. Zanesi, E. Callegari, S. Liu, H. Alder, S. Costinean, C. Fernandez-Cymering, S. Volinia, G. Guler, C.D. Morrison, K.K. Chan, G. Marcucci, G.A. Calin, K. Huebner, and C.M. Croce MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc. Natl. Acad. Sci. U.S.A. 104 2007 15805 15810
36. M. Tan, J. Wu, and Y. Cai Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer Biochem. Biophys. Res. Commun. 438 2013 673 679
37. L.R. Barkley, and C. Santocanale MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells Oncogenesis 2 2013 e57